Director of Drug Safety and Risk management
Saudi Food and Drug Authority , Saudi Arabia
Dr.Fawaz Alharbi is currently working as director of drug safety and risk management department in drug sector at SFDA. Dr.Alharbi holds a bachelor degree in pharmaceutical sciences from King Saud University, master of science in clinical pharmacology with distinction from University of Glasgow in the UK, and master and PhD degree in pharmacoepidemiology from Utrecht University in the Netherlands. Dr.Alharbi is one of the co-founders of the National Pharmacovigilance Centre (NPC) that officially launched in March 2009. His research interests are in fields of pharmacoepidemiology and pharmacovigilance.
Disclosure information not submitted.
Treatment Patterns and Effectiveness and Safety of Anticoagulant Therapy
Wednesday, August 28, 2024
1:30 PM – 3:00 PM CEST